期刊文献+

RBC-Y和RET-Y在肾性贫血患者铁缺乏监测中的应用 被引量:3

Application of RBC-Y and RET-Y in monitoring renal anemia patients with iron deficiency
下载PDF
导出
摘要 目的探讨RBC-Y和RET-Y在肾性贫血患者铁缺乏监测中的应用价值。方法收集慢性肾衰竭(CRF)引起的肾性贫血组和健康对照组血液标本,分别检测RBC-Y、RET-Y、铁蛋白(SF)、可溶性转铁蛋白受体(sTfR)等指标,以sTfR>2.25mg/L作为铁缺乏的"金标准",利用ROC曲线分析RBC-Y、RET-Y和SF等参数在诊断肾性贫血患者铁缺乏的性能。结果肾性贫血组与健康对照组间RBC-Y和RET-Y两参数结果差异有统计学意义(P<0.001),经ROC曲线分析RBC-Y、RET-Y和SF在诊断肾性贫血患者铁缺乏时曲线下面积分别为0.811、0.780、0.530,当临界值为151.6时,RBC-Y诊断铁缺乏的灵敏度为81.0%,特异性为75.0%;当临界值为1 580.5时,RET-Y诊断铁缺乏的灵敏度为74.6%,特异性为75.0%;当临界值为96μg/L时,SF诊断铁缺乏的灵敏度为61.9%,特异性为58.3%。结论 RBC-Y和RET-Y可作为CRF引起的肾性贫血患者铁缺乏的诊断指标。 Objective To explore the clinical value of RBC-Y and RET-Y in monitoring the iron deficiency of the patients who suffer with renal anemia .Methods Blood samples were collected from patients with renal anemia of CRF and normal control individuals ,then RBC-Y ,RET-Y ,SF and sTfR were detected respectively and sTfR 〉2 .25 mg/L was regarded as "gold standard"of the iron deficiency ,using ROC curve to analyze RBC-Y ,RET-Y and SF for the diagnosis of the iron deficiency of the patients who suffer with renal anemia was studied .Results There are significant differences in RBC-Y and RET-Y between renal anemia group and control group .The RBC-Y ,RET-Y and SF area under the ROC curve are 0 .811 ,0 .780 ,0 .530 ,the sensitivity of RBC-Y in diagnosing iron deficiency is 81 .0%and specificity is 75 .0% when the critical value is 151 .6 ;sensitivity of RET-Y is 74 .6% and specificity is 75 .0%when the critical value is 1 580 .5;sensitivity of SF is 61 .9% and specificity is 58 .3% when the critical value is 96μg/L .Conclusion RBC-Y and RET-Y could be used as an indicator of iron deficiency in patients with renal anemia of CRF .
出处 《检验医学与临床》 CAS 2014年第11期1458-1461,共4页 Laboratory Medicine and Clinic
基金 广东省中山市卫生局立项项目(2010043)
关键词 RBC—Y RET—Y 铁缺乏 可溶性转铁蛋白受体 肾性贫血 RBC-Y RET-Y RBC-Y RET-Y iron deficiency solubility transferring receptor renal anemia
  • 相关文献

参考文献24

  • 1王海燕 主译.慢性肾脏病及透析的临床实践指南[M].北京:人民卫生出版社,2003.69-75.
  • 2林沁,陈淑娇,庄永泽.静脉补铁对肾性贫血促红细胞生成素的治疗效果[J].临床肾脏病杂志,2006,6(3):102-104. 被引量:3
  • 3Jayaranee S,Sthaneshwar P. RET-Y and RBC-Y in the di agnosis of iron deficiency associated with anaemia of in flammation[J]. International Journal of Laboratory He matology, 2010,32 (23): 512-518.
  • 4Ng HY,Chen HC,Pan LL,et al. Clinical interpretation of reticulocyte hemoglobin content, RET-Y, in Chronic he- modialysis patients[J]. Nephron Clin Pract, 2009, 111 (36) :247-252.
  • 5Kickler TS, Borowitz MJ, Thompson RE. Ret-Y a meas- ure of reticulocyte size: a sensitive indicator of iron defi- ciency anemia[J]. Clin Lab Haem, 2004,26 (41 ) : 423-427.
  • 6崔明.新的红细胞参数鉴别缺铁性贫血与慢性病贫血的价值[J].现代检验医学杂志,2007,22(2):111-111. 被引量:2
  • 7CLSI. H26-P2 Validation, verification, and quality assur anee of automated hematology analyzers;proposed stand ard[S]. CLSI document. Wayne, PA:Clinical and Labora tory Standards Institute, 2009.
  • 8CLSI. EP15-A2 User Verification of Performance for Pre- cision and Trueness; Approved Guideline-Second Edition [S]. CLSI document. Wayne, PA : Clinical and Laboratory Standards Institute, 2006.
  • 9谌贻璞.用促红细胞生成素治疗肾性贫血必须合理补铁[J].肾脏病与透析肾移植杂志,2006,15(4):345-346. 被引量:37
  • 10Besarab A, Frinak S, Yee J. An indistinct balance: safety and efficacy of parenteral iron[J]. J Am Soc Nephol, 1999,10(9) : 2029-2043.

二级参考文献62

  • 1陈朝霞,崔明.未成熟网织红细胞指数鉴别贫血的分析[J].医学临床研究,2005,22(4):558-559. 被引量:7
  • 2陈卫中,倪宗瓒,潘晓平,刘元元,夏彦.用ROC曲线确定最佳临界点和可疑值范围[J].现代预防医学,2005,32(7):729-731. 被引量:207
  • 3姚斌,余斌杰,翁建平,林文栋.糖尿病患者治疗过程中果糖胺的动态观察[J].中国糖尿病杂志,1995,3(2):110-110. 被引量:3
  • 4杨玲,李连弟,陈育德,D.M.Parkin.中国乳腺癌发病死亡趋势的估计与预测[J].中华肿瘤杂志,2006,28(6):438-440. 被引量:278
  • 5Blask D E, Brainard G C, Dauchy R T, et al. Decreased melatonin production linked to light exposure [J].Caneer Res,2005,65 (23): 11174-11184.
  • 6Hanley J A, McNeil B J. A method of comparing the areas under receiver operating characteristic curves derived from the same cases [ J ]. Radiology, 1983, ( 148 ) : 839-843.
  • 7Richardson D. Clinical factors influencing sensitivity and respond to epoetin. Nephrol Dial Transplant,2002,17 ( Suppl 1 ) :53 - 59.
  • 8Drueke T. Hyporesponsiveness to recombinant human erythropoi- etin. Nephrol Dial Transplant,2001,16 ( Suppl 7 ) : 25 - 28.
  • 9Besarsb A. Evaluating iron sufficiency: A clearer view. Kidney Int,2001,60 (6) :2412 - 2414.
  • 10Brugnara C. Reticulocyte cellular indices : a new approach in the diagnosis of anemias and monitoring of erythropoietic function. Crit Rev Clin Lab Sci ,2000,37(2) :93 -130.

共引文献300

同被引文献30

引证文献3

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部